Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model

Platinum is reported to have adjuvant immune properties, whether oxaliplatin (OXA) could be utilized to synergize with anti-programmed cell death-1 (PD-1) antibody or anti-NKG2D (natural-killer group 2, member D) antibody is investigated. Subcutaneous A549 lung cancer and murine Lewis lung carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Min, Lin, Dan, Yan, Nahan, Li, Huiling, Li, Jieping, Huang, Zongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Pre-Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734624/
https://www.ncbi.nlm.nih.gov/pubmed/34561996
http://dx.doi.org/10.1097/CAD.0000000000001248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734624/
https://www.ncbi.nlm.nih.gov/pubmed/34561996
http://dx.doi.org/10.1097/CAD.0000000000001248

Ejemplares similares